Literature DB >> 12674637

[Expression of porcine interferon-gamma gene in Pichia pastoris and its effect of inhibiting porcine reproductive and respiratory syndrome virus].

Jian-Qing Wan1, Wen-Xue Wu, Chun Xia.   

Abstract

In order to develop recombinant porcine Interferon-gamma (rPoIFN-gamma) to prevent porcine viral infection, PoIFN-gamma cDNA lacking the signal peptide was expressed in Pichia pastoris GS115 strain, and the effect of rPoIFN-gamma on porcine reproductive and respiratory syndrome virus (PRRSV) was investigated. The PoIFN-gamma gene was inserted into integrative vector pHIL-S1, and the recombinant GS115 strain (pHIL-S1/PoIFN-gamma) was constructed by homologues recombinant. The rPoIFN-gamma protein was 18 kD with an expressing yield of 18% was assayed by SDS-PAGE and Western blot, respectively. The anti-viral activity of rPoIFN-gamma was in the range of 450-540 u/mL. In addition, the effect of rPoIFN-gamma ant-PRRSV was determined using CPE50 method. The results indicated that high concentration of rPoIFN-gamma could inhibit PRRSV on Marc-145 cell line. The rPoIFN-gamma is a potential drug for prevention and treatment of various kinds of viral pig diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12674637

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  2 in total

1.  Establishment of a stable CHO cell line with high level expression of recombinant porcine IFN-β.

Authors:  Weiye Chen; Wenyan Cao; Huijun Zhao; Qianqian Hu; Linmao Qu; Sen Hu; Jinying Ge; Zhiyuan Wen; Xijun Wang; Haobo Li; Kehe Huang; Zhigao Bu
Journal:  Cytokine       Date:  2011-04-01       Impact factor: 3.861

2.  Equine arteritis virus does not induce interferon production in equine endothelial cells: identification of nonstructural protein 1 as a main interferon antagonist.

Authors:  Yun Young Go; Yanhua Li; Zhenhai Chen; Mingyuan Han; Dongwan Yoo; Ying Fang; Udeni B R Balasuriya
Journal:  Biomed Res Int       Date:  2014-05-25       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.